1
|
Kocić J, Zečević N, Jagodić J, Ardalić D, Miković Ž, Kotur-Stevuljević J, Manojlović D, Stojsavljević A. Exploring serum trace element shifts: Implications for cervical intraepithelial neoplasia. J Trace Elem Med Biol 2024; 86:127531. [PMID: 39270537 DOI: 10.1016/j.jtemb.2024.127531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2024] [Revised: 09/06/2024] [Accepted: 09/09/2024] [Indexed: 09/15/2024]
Abstract
BACKGROUND Cervical intraepithelial neoplasia (CIN) represents a premalignant state presumably related to perturbations in circulating levels of trace elements. MATERIALS AND METHODS Employing inductively coupled plasma mass spectrometry (ICP-MS), we quantified essential and toxic trace elements in the sera of 60 women diagnosed with CIN and 60 age-matched healthy counterparts. RESULTS Our investigation revealed a noteworthy higher levels in serum of Mn, Zn, and Pb, as well as lower levels in Ni, Se, Rb, and Mo levels within the CIN cohort. Levels of Mn, Zn, and Pb were higher by approximately 5.5-fold, 3.0-fold, and 7.5-fold, respectively, while Mo levels exhibited an approximate 4.5-fold reduction in CIN sera compared to the control group. While the study provided valuable insights into trace element variations, it's important to note that the adult Serbian population is considered Zn-deficient, so the Zn data should be interpreted with caution. Age stratification (30-40 vs. 40-50 vs. 50-60 years), smoking status (smokers vs. nonsmokers), and CIN severity (CIN 2 vs. CIN 3) yielded no significant disparities in elemental profiles. Among the 10 proposed ratios, 5 demonstrated a significant surge in CIN sera relative to controls: Mn/Se, Mn/Mo, Zn/Se, Zn/Mo, and Se/Mo. Correlation analysis of trace element levels revealed a predominantly consistent pattern between CIN cases and healthy subjects, except for Zn and its negative correlations (antagonistic interactions) with other analyzed trace elements. CONCLUSION Our findings underscore differences in serum levels of specific trace elements in CIN cases versus controls, implicating their potential involvement in the underlying pathophysiological cascades culminating in cervical neoplasms.
Collapse
Affiliation(s)
- Jovana Kocić
- Clinic for Gynecology and Obstetrics "Narodni front", Kraljice Natalije 62, Belgrade, Serbia
| | - Nebojša Zečević
- Clinic for Gynecology and Obstetrics "Narodni front", Kraljice Natalije 62, Belgrade, Serbia; University of Belgrade, Faculty of Medicine, Doktora Subotića 8, Belgrade, Serbia
| | - Jovana Jagodić
- University of Belgrade, Faculty of Chemistry, Studentski trg 12-16, Belgrade, Serbia
| | - Daniela Ardalić
- Clinic for Gynecology and Obstetrics "Narodni front", Kraljice Natalije 62, Belgrade, Serbia
| | - Željko Miković
- Clinic for Gynecology and Obstetrics "Narodni front", Kraljice Natalije 62, Belgrade, Serbia; University of Belgrade, Faculty of Medicine, Doktora Subotića 8, Belgrade, Serbia
| | | | - Dragan Manojlović
- University of Belgrade, Faculty of Medicine, Doktora Subotića 8, Belgrade, Serbia
| | - Aleksandar Stojsavljević
- Innovative Centre of the Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, Belgrade, Serbia.
| |
Collapse
|
2
|
Li L, Jiang M, Wang W, Cao X, Ma Q, Han J, Liu Z, Huang Y, Chen Y. DNA demethylase TET2-mediated reduction of HADHB expression contributes to cadmium-induced malignant progression of colorectal cancer. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 2024; 280:116579. [PMID: 38865940 DOI: 10.1016/j.ecoenv.2024.116579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/11/2023] [Revised: 05/27/2024] [Accepted: 06/08/2024] [Indexed: 06/14/2024]
Abstract
Environmental exposure to the cadmium (Cd) has been shown to be a risk factor for colorectal cancer (CRC) progression, but the exact mechanism has not been fully elucidated. In this study, we found that chronic Cd (3 μM) exposure promoted the proliferation, adhesion, migration, and invasion of CRC cells in vitro, as well as lung metastasis in vivo. RNA-seq and TCGA-COAD datasets revealed that decreased hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta (HADHB) expression may be a crucial factor in Cd-induced CRC progression. Further analysis using qRT-PCR and tissue microarrays from CRC patients showed that HADHB expression was significantly reduced in CRC tissues compared to adjacent normal tissues, and low HADHB expression was associated with adverse clinical features and poor overall survival, either directly or through TNM stage. Furthermore, HADHB was found to play an important role in the Cd-induced malignant metastatic phenotype of CRC cells and lung metastasis in mice. Mechanistically, we discovered that chronic Cd exposure resulted in hypermethylation of the HADHB promoter region via inhibition of DNA demethylase tet methylcytosine dioxygenase 2 (TET2), which then led to decreased HADHB expression and activation of the FAK signaling pathway, and ultimately contributed to CRC progression. In conclusion, this study provided a new potential insight and evaluable biomarker for Cd exposure-induced CRC progression and treatment.
Collapse
Affiliation(s)
- Lingling Li
- Key Lab of Environment and Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Key Laboratory of Human Genetics and Environmental Medicine, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
| | - Min Jiang
- Key Lab of Environment and Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Key Laboratory of Human Genetics and Environmental Medicine, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
| | - Weimin Wang
- Department of Oncology, Yixing People's Hospital, Yixing, Jiangsu 214200, China
| | - Xingyue Cao
- Key Lab of Environment and Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Key Laboratory of Human Genetics and Environmental Medicine, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
| | - Qun Ma
- Key Lab of Environment and Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Key Laboratory of Human Genetics and Environmental Medicine, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
| | - Jingyi Han
- Key Lab of Environment and Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Key Laboratory of Human Genetics and Environmental Medicine, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
| | - Zixuan Liu
- Key Lab of Environment and Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Key Laboratory of Human Genetics and Environmental Medicine, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
| | - Yefei Huang
- Key Lab of Environment and Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Key Laboratory of Human Genetics and Environmental Medicine, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
| | - Yansu Chen
- Key Lab of Environment and Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Key Laboratory of Human Genetics and Environmental Medicine, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
| |
Collapse
|
3
|
Squitti R, Pal A, Dhar A, Shamim MA, Ventriglia M, Simonelli I, Rani I, Sharma A, Rizzo G, Tondolo V, Goswami K, Rongioletti M. Serum copper status of patients with colorectal cancer: A systematic review and meta-analysis. J Trace Elem Med Biol 2024; 82:127370. [PMID: 38159434 DOI: 10.1016/j.jtemb.2023.127370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Revised: 12/15/2023] [Accepted: 12/18/2023] [Indexed: 01/03/2024]
Abstract
BACKGROUND Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide and a public health problem. Several clinical studies have shown that copper (Cu) is involved in carcinogenesis, possibly via cuproptosis, a new form of programmed cell death, but the conclusions from published reports are inconsistent. This study aimed at evaluating the potential of Cu dysregulation as a CRC susceptibility factor. METHODS In this systematic review and meta-analysis, we searched Cochrane Library, EBSCOhost, EMBASE, ProQuest, PubMed/MEDLINE, Scopus, and Web of Science for studies reporting serum Cu concentrations in CRC patients and controls from articles published till June 2023. The studies included reported measurements of serum/plasma/blood Cu levels. Meta-analyses were performed as well as study quality, heterogeneity, and small study effects were assessed. Based on a random effects model, summary standardized mean differences (SMDs) and the corresponding 95% confidence intervals (95% CIs) were applied to compare the levels of Cu between CRC patients and controls. RESULTS 26 studies with a pooled total of9628 participants and 2578 CRC cases were included. The pooled SMD was equal to 0.85 (95% CIs -0.44; 2.14) showing that the CRC patients had higher mean Cu levels than the control subjects, but the difference was not significant (p = 0.185) and the heterogeneity was very high, I2 = 97.9% (95% CIs: 97.5-98.3%; p < 0.001). CONCLUSION The pooled results were inconclusive, likely due to discordant results and inaccuracy in reporting data of some studies; further research is needed to establish whether Cu dysregulation might contribute to the CRC risk and whether it might reflect different CRC grades.
Collapse
Affiliation(s)
- Rosanna Squitti
- Department of Laboratory Science, Ospedale Isola Tiberina - Gemelli Isola, 00186 Rome, Italy.
| | - Amit Pal
- Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Kalyani 741245, India
| | - Aninda Dhar
- Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Kalyani 741245, India
| | | | - Mariacarla Ventriglia
- Clinical Research Centre, Ospedale Isola Tiberina - Gemelli Isola, 00186 Rome, Italy
| | - Ilaria Simonelli
- Clinical Research Centre, Ospedale Isola Tiberina - Gemelli Isola, 00186 Rome, Italy
| | - Isha Rani
- Department of Biochemistry, Maharishi Markandeshwar College of Medical Sciences and Research (MMCMSR), Ambala, India
| | - Aaina Sharma
- Department of Community Medicine and School of Public Health, PGIMER, Chandigarh, India
| | - Gianluca Rizzo
- Digestive and Colorectal Surgery, Ospedale Isola Tiberina - Gemelli Isola, 00186 Rome, Italy; Digestive Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | - Vincenzo Tondolo
- Digestive and Colorectal Surgery, Ospedale Isola Tiberina - Gemelli Isola, 00186 Rome, Italy; Digestive Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
| | - Kalyan Goswami
- Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Kalyani 741245, India
| | - Mauro Rongioletti
- Department of Laboratory Science, Ospedale Isola Tiberina - Gemelli Isola, 00186 Rome, Italy
| |
Collapse
|
4
|
Kazi M, Patel H, Choudhary N, Jain A, Dudhat S, Naik S, Desouza A, Saklani A. Spatial Epidemiology of Signet-ring Cell Colorectal Cancer in India. SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES 2024; 12:71-75. [PMID: 38362099 PMCID: PMC10866387 DOI: 10.4103/sjmms.sjmms_260_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Revised: 08/19/2023] [Accepted: 09/12/2023] [Indexed: 02/17/2024]
Abstract
Background Signet-ring cell colorectal carcinoma (SRCC) is an extremely aggressive yet uncommon histologic subtype of colorectal cancer (CRC) with an unknown etiology. There is a stark difference in the prevalence of signet cancers between Western countries and the Indian subcontinent; however, India itself is a vast and diverse country with variable cancer incidence. Objective To study the spatial epidemiology of SRCC in India for identifying regions with high prevalence. Methods This retrospective study included all patients diagnosed with colorectal adenocarcinoma at Tata Memorial Hospital, the largest colorectal cancer referral unit in India, between January 2020 and December 2022. Geocoding based on the location of the residence was done to map the incidences. Comparisons were performed between the proportion of signet cell and non-signet colorectal cancers. Results A total of 4100 patients with colon or rectal adenocarcinomas were included, of which signet cell histology was found in 624 (15%) patients. SRCC accounted for the highest proportions of CRCs in the Central (19%) and Northern (19%) regions, and the lowest in the North-Eastern (10%) and Western (12%) regions of India (P < 0.001), with non-overlapping confidence intervals. Compared with patients with non-signet CRCs, those with SRCC more commonly had colon cancers (22% vs. 17%; P = 0.003) and belonged to a lower socioeconomic background (67% vs. 59%; P < 0.001). Conclusions This study found that SRCCs accounted for a significant proportion of CRC cases in India, but there was no substantial disparity in distribution across regions.
Collapse
Affiliation(s)
- Mufaddal Kazi
- Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
- Department of Surgical Oncology, Homi Bhabha National Institute, Mumbai, India
- Advanced Center for Treatment, Research and Education in Cancer, Navi Mumbai, Maharashtra, India
| | - Harshit Patel
- Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
- Department of Surgical Oncology, Homi Bhabha National Institute, Mumbai, India
| | - Nazia Choudhary
- Department of Surgical Oncology, Homi Bhabha National Institute, Mumbai, India
- Advanced Center for Treatment, Research and Education in Cancer, Navi Mumbai, Maharashtra, India
| | - Agrim Jain
- Department of Surgical Oncology, Homi Bhabha National Institute, Mumbai, India
- Deparmtent of Clinical Research Secretariat, Tata Memorial Hospital, Mumbai, India
| | - Shruti Dudhat
- Department of Surgical Oncology, Homi Bhabha National Institute, Mumbai, India
- Deparmtent of Clinical Research Secretariat, Tata Memorial Hospital, Mumbai, India
| | - Sakshi Naik
- Department of Surgical Oncology, Homi Bhabha National Institute, Mumbai, India
- Deparmtent of Clinical Research Secretariat, Tata Memorial Hospital, Mumbai, India
| | - Ashwin Desouza
- Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
- Department of Surgical Oncology, Homi Bhabha National Institute, Mumbai, India
| | - Avanish Saklani
- Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
- Department of Surgical Oncology, Homi Bhabha National Institute, Mumbai, India
| |
Collapse
|